Covalon Technologies Ltd
XTSX:COV
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.97
4.07
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Covalon Technologies Ltd
Covalon Technologies Ltd
Cash & Cash Equivalents
Covalon Technologies Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Covalon Technologies Ltd
XTSX:COV
|
Cash & Cash Equivalents
CA$9.4m
|
CAGR 3-Years
39%
|
CAGR 5-Years
52%
|
CAGR 10-Years
9%
|
|
|
B
|
Bright Minds Biosciences Inc
CNSX:DRUG
|
Cash & Cash Equivalents
CA$19.8m
|
CAGR 3-Years
191%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Theratechnologies Inc
TSX:TH
|
Cash & Cash Equivalents
$38.9m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
5%
|
CAGR 10-Years
33%
|
|
|
ESSA Pharma Inc
NASDAQ:EPIX
|
Cash & Cash Equivalents
$103.7m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
14%
|
CAGR 10-Years
40%
|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Cash & Cash Equivalents
$36.6m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
4%
|
|
|
Spectral Medical Inc
TSX:EDT
|
Cash & Cash Equivalents
CA$5.8m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
14%
|
CAGR 10-Years
-7%
|
|
Covalon Technologies Ltd
Glance View
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2004-09-03. The firm uses science and technology to help solve medical challenges associated with prevention, detection and management of areas such as infection, tissue repair and medical devices. Its products include Advanced Wound Care, Vascular Access, Perioperative Care and Urology. Advanced Wound Care is designed for the treatment of a range of wounds and offers CovaWound and ColActive brands. Vascular Access portfolio includes CovaView IV, a transparent film dressing that provides an effective barrier against external contaminants, including fluid, bacteria, and yeast. Perioperative care refers to the three Phases of surgery, including preoperative, intraoperative, and postoperative care and its brands include MediClear and SurgiClear.
See Also
What is Covalon Technologies Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
9.4m
CAD
Based on the financial report for Jun 30, 2024, Covalon Technologies Ltd's Cash & Cash Equivalents amounts to 9.4m CAD.
What is Covalon Technologies Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
9%
Over the last year, the Cash & Cash Equivalents growth was 2%. The average annual Cash & Cash Equivalents growth rates for Covalon Technologies Ltd have been 39% over the past three years , 52% over the past five years , and 9% over the past ten years .
You don't have any saved screeners yet
